Companies: 10,795·Total market cap: $144.5T

InterCure Ltd.

InterCure Ltd.

INCRNASDAQHealthcare● Active

$0.99

$-0.03(-2.94%)

Market Cap$54134522

P/E Ratio—

52W High$1.77

52W Low$0.68

Avg Volume33K

Open$1.01

Beta0.57

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

InterCure Ltd.（INCR）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · INCR · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.61Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$243.1MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding56.8MShares outstanding history

Next EarningsTBAEarnings history

探索 InterCure Ltd. 数据

分析师预测$— · Buy

股息不分红

营收$270.2M+13.13%

盈利EPS $-0.63+55.63%

财务快照

FY 2025Revenue$270.2M▲ +13.13% YoY

202320242025

FY 2025Net Income-$35.7M▲ +47.33% YoY

202320242025

FY 2025EPS$-0.63▲ +55.63% YoY

202320242025

TTM:Revenue: $243.1MNet Income: -$70.9MEPS: $-1.61View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.99Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$0.99-2.94%$54.1M #2

American Well Corporation

$8.75+1.51%$146.2M #3

Assertio Holdings, Inc.

$23.43-0.04%$151.4M #4

Biomea Fusion, Inc.

$1.15-9.45%$68.4M #5

CAMP4 Therapeutics Corporation

$4.09-0.49%$86.9M #6

Cardiol Therapeutics Inc.

$1.08-2.70%$120.8M

股票表现

1D-2.94%

1W-5.71%

1M+18.03%

3M+20.73%

YTD+8.79%

1Y-34.87%

5Y-87.39%

关于 InterCure Ltd.

CEOAlexander Rabinovich

IPO DateJan 28, 2019

Employees320

CountryIL

Websiteintercure.co

InterCure Ltd. including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturin…

Drug Manufacturers - Specialty & Generic HealthcareNASDAQIL

关于股票概览与关键数据

InterCure Ltd.（INCR）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Jan 28, 2019 在 NASDAQ 上市。截至最近交易日，INCR 股价为 $0.99，市值约为 $54.1M。过去12个月累计回报 -34.87%，年初至今回报 +8.79%。

根据 1 位华尔街分析师，InterCure Ltd. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 InterCure Ltd. 营收 $270.2M，净利润 -$35.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，InterCure Ltd.（INCR）股价为 $0.99，在 NASDAQ 上市，52周区间为 $0.68 – $1.77。

INCR 最新股价INCR quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议